Skip to content Accessibility tools

What is the 4Kscore® Prostate Cancer Biomarker Test?

Using a clinically validated algorithm, The 4Kscore® Test integrates results of Total PSA, Free PSA, Intact PSA, Human Kallikrein 2 (hK2) plus age, prior biopsy status, and DRE (if available), and generates a probability score of detecting Gleason ≥7 / Grade Group ≥2 prostate cancer on biopsy.

What is the 4Kscore® Prostate Cancer Biomarker Test

Guideline Alignment

The 4Kscore Test is consistent with recommendations from leading professional organizations that endorse the use of secondary biomarkers prior to biopsy:

Both the NCCN Prostate Cancer Early Detection Guidelines and The AUA/SUO Early Detection of Prostate Cancer Guideline recognize kallikrein-based tests as tools that may improve specificity and reduce avoidable procedures.